Cellectis

430 E 29th St
New York, NY 10016

Cellectis is a clinical-stage biotechnology company based in New York, NY, specializing in innovative gene-editing technologies, notably its proprietary TALEN technology. The company is focused on developing life-saving cell and gene therapies, with a commitment to creating off-the-shelf CAR T therapies designed to address significant challenges in cancer treatment.

With over 25 years of innovation, Cellectis boasts a robust intellectual property portfolio, featuring more than 100 patent families and strategic partnerships with leading firms such as Allogene and AstraZeneca. Their mission is to enhance the accessibility and safety of immunotherapies for a broad patient population, ultimately aiming to advance therapies beyond cancer.

Generated from the website

Own this business?
See a problem?

You might also like